Gilead Sciences, Inc. (GIS.DE) XETRA

Currency In EUR

AD

Valuation

Market Cap155.3B
Enterprise Value173.78B
P/E Ratio17.5
PEG Ratio0.32
Price/Sales Ratio5.42
Price/Book Ratio6.86
Enterprise/Revenue5.91
Enterprise/EBITDA12.54

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.31
Operating Margin0.38
AD

Management Effectiveness

Return On Assets0.16
Return On Equity0.42

Income Statement

Revenue29.45B
Revenue/Share23.94
Gross Profit25.52B
EBITDA13.58B
Net Income8.51B
Diluted EPS6.78

Balance Sheet

Total Cash9.78B
Total Cash/Share7.9
Total Debt22.09B
Total Debt/Equity0.94
Current Ratio1.97
Book Value Per Share18.87

Price History

52-Week Change19.27
52-Week High132
52-Week Low92.3
Moving Average 50 Days112.21
Moving Average 200 Days112.75

Statistics

Average Volume1,002
Shares Outstanding1.24B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate3.22
Trailing Annual Dividend Yield2.48
Payout Ratio0.44
Last Split Factor2:1
Last Split DateJanuary 28, 2013
AD